Aurobindo Pharma shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters51.88%no change
Foreign investors (FII)17.41%+1.03 pts
Domestic institutions (DII)24.42%−0.68 pts
of which mutual funds16.31%−0.40 pts
of which insurance companies4.84%
Public6.29%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AUROPHARMA₹1,644.80

Aurobindo Pharma Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMADRREDDYCIPLAFORTISLUPINALKEMLAURUSLABSMANKINDMcap ₹95,530 Cr
Holding % of Total Shares
12 Months Ending
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group51.8051.8251.8251.8251.8251.8251.8251.8251.8851.88
FII / FPI16.7316.5916.2915.3314.3714.2113.9415.2416.3817.41
DII24.7725.1325.2026.2326.9327.6027.6825.8725.1024.42
Mutual Funds19.1718.5317.8118.2118.9619.3019.5217.7916.7116.31
Latest: 2026-09-30 · 62 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.